{
    "nctId": "NCT01016665",
    "briefTitle": "Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy",
    "officialTitle": "Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy. A Prospective Placebo Double Blind Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 71,
    "primaryOutcomeMeasure": "Expression of progesterone",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Invasive breast cancer post-menopausal women\n* Estrogen and/or progesterone receptor positive\n\nExclusion Criteria:\n\n* Patients with endocrine disease\n* Hormone therapy users or those who had been pregnant in the last 12 months before the diagnosis\n* Patients with a negative expression for estrogen and/or progesterone receptors\n* Women with a history of thromboembolism\n* Patients who had previously undergone any treatment for breast cancer",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}